920527--5/26/2010--PSS_WORLD_MEDICAL

related topics

{regulation, government, change}

{customer, product, revenue}

{product, market, service}

{acquisition, growth, future}

{condition, economic, financial}

{product, liability, claim}

{operation, natural, condition}

{operation, international, foreign}

{system, service, information}

{debt, indebtedness, cash}

{property, intellectual, protect}

{stock, price, share}

{personnel, key, retain}

{stock, price, operating}

{regulation, change, law}

{gas, price, oil}

{cost, regulation, environmental}

{financial, litigation, operation}

General economic conditions, including the current global economic slowdown and other events in the global economy may materially adversely impact the Company s operating results. Trends in healthcare spending and competitive bidding as well as the recently enacted healthcare reform legislation may impact the Company s results of operations. Numerous factors, many of which cannot be controlled by the Company, may cause the Company s net sales and results of operations to fluctuate, which may adversely affect the market price of the Company s common stock. The viability of the Company s customers may be threatened by various factors. The Company may not be able to continue to successfully compete with other medical supply companies and direct manufacturers. The Company s future operating results can be affected by its relationships with its customers, sales representatives, and senior management team. The Company relies extensively on its relationships, significant distribution agreements and other purchasing arrangements with suppliers. Cost increases for the Company s products may impact the Company s results of operations. The Company may face increasing competitive pricing pressures on sales to its customers. Expansion of GPO or hospital purchasing power and the multi-tiered costing structure may place the Company at a competitive disadvantage. The Company accesses multi-tiered priced products from other distributors at prices lower than the manufacturers list prices. The operating costs of the Company s delivery fleet could increase due to fuel price fluctuations and/or service interruptions by third parties. The Company s strategy for growth may not result in additional net sales or operating income and may have an adverse effect on working capital, operating cash flow, and results of operations. Circumstances associated with the Company s acquisition strategy could adversely affect the Company s results of operations and financial condition. The Company s ability to carry out its global sourcing strategy, which includes sourcing products from foreign markets subject to political, economic and legal uncertainties, may affect the Company s overall profitability. The Company s business is dependent on data processing systems critical to the business operations. The Company s future results of operations could be adversely affected by operational disruptions due to natural disasters, particularly in regions susceptible to hurricanes. The Company s significant investment in inventory may be exposed to risk of product obsolescence or decline in market valuation. The Company s indebtedness may limit its ability to obtain additional financing in the future and may limit its flexibility to react to industry or economic conditions. The price of the Company s common stock and the trading value of the senior convertible notes may be volatile. The Company faces potential litigation and liability exposure for product liability and other claims against the Company. The Company faces risk that its proprietary rights may infringe on the rights of third parties and that the protection offered by its proprietary rights may not be adequate. Failure to comply with existing and future regulatory and legal requirements could adversely affect the Company s results of operations and financial condition.

Full 10-K form ▸

920527--5/26/2010--PSS_WORLD_MEDICAL_INC